Skip to Main Content


Skip Nav Destination

Abstract B278: PR610: A novel hypoxia-selective tyrosine kinase inhibitor in phase I clinical trial.

Mol Cancer Ther (2013) 12 (11_Supplement): B278.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Irma Telarovic
  • Roland H. Wenger
  • Martin Pruschy
Journal of Experimental & Clinical Cancer Research (2021) 40 (1)
Close Modal

or Create an Account

Close Modal
Close Modal